In just two weeks, Novartis will resume its attack on people's access to affordable generic medicines, by challenging A  PART OF  India's PATENT  law that puts people above corporate profits in the name of public health.  The Novartis vs. India case heads to the Supreme Court on 28 February. 
ADD YOUR VOICE and join Medecins Sans Frontieres (MSF) in taking action before its too late – jump on Twitter and tell Novartis to STOP its attack against the pharmacy of the developing world!   
MSF relies on affordable medicines produced in India to do its work...



Read the full post on www.tnpp.org